Nanotechnology-Mediated Targeting of Tumor Angiogenesis

Vascular Cell - United Kingdom
doi 10.1186/2045-824x-3-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Publiverse Online S.R.L

Related search

Recent Progress in Tumor pH Targeting Nanotechnology

Journal of Controlled Release
Pharmaceutical Science
2008English

Triggering Tumor Immunity Through Angiogenesis Targeting

Clinical Cancer Research
Cancer ResearchOncology
2007English

Targeting Vascular NADPH Oxidase 1 Blocks Tumor Angiogenesis Through a PPARα Mediated Mechanism

PLoS ONE
Multidisciplinary
2011English

Targeting the Tumor Microenvironment: Focus on Angiogenesis

Journal of Oncology
Oncology
2012English

Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction

Frontiers in Cell and Developmental Biology
Developmental BiologyCell Biology
2016English

The Role IL-1 in Tumor-Mediated Angiogenesis

Frontiers in Physiology
Physiology
2014English

MiR-199b-5p Suppresses Tumor Angiogenesis Mediated by Vascular Endothelial Cells in Breast Cancer by Targeting ALK1

Frontiers in Genetics
GeneticsMolecular Medicine
2020English

Pristimerin, a Triterpenoid, Inhibits Tumor Angiogenesis by Targeting VEGFR2 Activation

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2012English

pH-sensitive Oncolytic Adenovirus Hybrid Targeting Acidic Tumor Microenvironment and Angiogenesis

Journal of Controlled Release
Pharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy